Pfizer and Astellas report positive results of Xtandi in cancer
Pfizer partnered with Astellas Pharma to develop Xtandi for the treatment of prostate cancer. Credit: Lauri Silvennoinen.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more